1,355
Views
3
CrossRef citations to date
0
Altmetric
Articles

Clostridioides (Clostridium) difficile carriage in asymptomatic children since 2010: a narrative review

ORCID Icon, , , , , & show all
Pages 1228-1236 | Received 15 Apr 2019, Accepted 26 Jul 2019, Published online: 08 Aug 2019

References

  • Jones AM, Kuijper EJ, Wilcox MH. Clostridium difficile: a European perspective. J Infect. 2013;66:115–128.
  • Prechter F, Katzer K, Bauer M, et al. Sleeping with the enemy: Clostridium difficile infection in the intensive care unit. Crit Care. 2017;21:260.
  • Alasmari F, Seiler SM, Hink T, et al. Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin Infect Dis. 2014;59:216–222.
  • Kazanowski M, Smolarek S, Kinnarney F, et al. Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities-a systematic review. Tech Coloproctol. 2014;18:223–232.
  • Rea MC, O'Sullivan O, Shanahan F, et al. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol. 2012;50:867–875.
  • Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478–498. quiz 499.
  • Weaver L, Michels HT, Keevil CW. Survival of Clostridium difficile on copper and steel: futuristic options for hospital hygiene. J Hosp Infect. 2008;68:145–151.
  • Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107:89–95.
  • Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372:1539–1548.
  • Martínez-Meléndez A, Camacho-Ortiz A, Morfin-Otero R, et al. Current knowledge on the laboratory diagnosis of Clostridium difficile infection. WJG. 2017;23:1552–1567.
  • Spigaglia P, Barbanti F, Castagnola E, et al. Clostridium difficile causing pediatric infections: New findings from a hospital-based study in Italy. Anaerobe. 2017;48:262–268.
  • Boyanova L, Kolarov R, Mitov I. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe. 2015;31:4–10.
  • Galdys AL, Nelson JS, Shutt KA, et al. Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania. J Clin Microbiol. 2014;52:2406–2409.
  • Curry SR, Muto CA, Schlackman JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57:1094–1102.
  • Hink T, Burnham CA, Dubberke ER. A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens. Anaerobe. 2013;19:39–43.
  • Terhes G, Urbán E, Sóki J, et al. Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary. J Clin Microbiol. 2004;42:4316–4318.
  • Persson S, Torpdahl M, Olsen KE. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect. 2008;14:1057–1064.
  • Persson S, Jensen JN, Olsen KE. Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC. J Clin Microbiol. 2011;49:2300–4299.
  • Furuya-Kanamori L, Marquess J, Yakob L, et al. Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis. 2015;15:516. [cited 2019 Jun 24]
  • Hung YP, Lee JC, Lin HJ, et al. Clinical impact of Clostridium difficile colonization. J Microbiol Immunol Infect. 2015; 48241–48248.
  • Jain T, Croswell C, Urday-Cornejo V, et al. Clostridium difficile colonization in hematopoietic stem cell transplant recipients: a prospective study of the epidemiology and outcomes involving toxigenic and nontoxigenic strains. Biol Blood Marrow Transplant. 2016;22:157–163.
  • Brouwer MS, Roberts AP, Hussain H, et al. Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers. Nat Commun. 2013;4:2601. [cited 2019 Jun 24].
  • Dominguez SR, Dolan SA, West K, et al. High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients. Clin Infect Dis. 2014;59:401–403.
  • Nagy E. What do we know about the diagnostics, treatment and epidemiology of Clostridioides (Clostridium) difficile infection in Europe? J Infect Chemother. 2018;24:164–170.
  • Rousseau C, Lemée L, Le Monnier A, et al. Prevalence and diversity of Clostridium difficile strains in infants. J Med Microbiol. 2011;60:1112–1118.
  • Rousseau C, Poilane I, Pontual L, et al. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. CID. 2012;55:1209–1215.
  • Furuichi M, Imajo E, Sato Y, et al. Characteristics of Clostridium difficile colonization in Japanese children. J Infect Chemother. 2014;20:307–311.
  • Wang Y, Guo S, Zhao CN, et al. [Colonization rate of Clostridium difficile in healthy children]. Zhonghua Er Ke Za Zhi. 2017;55:294–297.
  • Stoesser N, Eyre DW, Quan TP, et al. Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains. PLoS One. 2017;12:e0182307. [cited 2019 Jun 24].
  • Cui Q-Q, Yang J, Niu Y-N, et al. Epidemiological investigation of Clostridioides difficile colonization in Chinese community infants. Anaerobe. 2019;56:116–123.
  • Ferraris L, Couturier J, Eckert C, et al. Carriage and colonization of C. difficile in preterm neonates: A longitudinal prospective study. PLoS One. 2019;14:e0212568. [cited 2019 Jun 24].
  • Terveer EM, Crobach MJ, Sanders IM, et al. Detection of Clostridium difficile in feces of asymptomatic patients admitted to the hospital. J Clin Microbiol. 2017;55:403–411.
  • Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr. 2010;51:2–7.
  • Borali E, De Giacomo C. Clostridium difficile infection in children: a review. J Pediatr Gastroenterol Nutr. 2016;63:e130–e140.
  • Lees EA, Miyajima F, Pirmohamed M, et al. The role of Clostridium difficile in the paediatric and neonatal gut – a narrative review. Eur J Clin Microbiol Infect Dis. 2016;35:1047–1057.
  • Janssen I, Cooper P, Gunka K, et al. High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana. Int J Med Microbiol. 2016;306:652–656.
  • Kaarme J, Hickman RA, Nevéus T, et al. Reassuringly low carriage of enteropathogens among healthy Swedish children in day care centres. Public Health. 2016;140:221–227.
  • Enserink R, Scholts R, Bruijning-Verhagen P, et al. High detection rates of enteropathogens in asymptomatic children attending day care. PLoS One. 2014;9:e89496. [cited 2019 Jun 24].
  • Faden HS, Dryja D. Importance of asymptomatic shedding of Clostridium difficile in environmental contamination of a neonatal intensive care unit. Am J Infect Control. 2015;43:887–888.
  • Beniwal-Patel P, Stein D, Munoz-Price LS. The Juncture between Clostridium difficile infection and inflammatory bowel diseases. Clin Infect Dis. 2019;69:366–372.
  • Hourigan SK, Chirumamilla SR, Ross T, et al. Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2744–2752.
  • Lamousé-Smith ES, Weber S, Rossi RF, et al. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;57:293–297.
  • Martinelli M, Strisciuglio C, Veres G, et al. Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study. Inflamm Bowel Dis. 2014;20:2219–2225.
  • Boyanova L, Markovska R, Hadzhiyski P, et al. Recurrent Clostridioides (Clostridium) difficile infection in a patient suffering from inflammatory bowel disease and benefits of resistotyping. Diagn Microbiol Infect Dis. 2019;94:334–336.
  • Hourigan SK, Sears CL, Oliva-Hemker M. Clostridium difficile infection in pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:1020–1025.
  • Chang TH, Hsu WY, Yang TI, et al. Increased age and proton pump inhibitors are associated with severe Clostridium difficile infections in children. J Microbiol Immunol Infect. 2018. [cited 2019 Jun 24]. pii: S1684-1182(18)30183-X.
  • Kellermayer R. Burdening questions about Clostridium difficile in pediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr. 2015;60:421–422.
  • Rätsep M, Kõljalg S, Sepp E, et al. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection. Anaerobe. 2017;47:94–103.
  • Suskind DL, Lee D, Solan P, et al. Dietary therapy for Clostridium difficile colonization: A case series. Anaerobe. 2019;57:1–3.